Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology

W. Flaig, Thomas; E. Spiess, Philippe; Abern, Michael; Bangs, Rick; Bangs, Rick; Begovic, Jovan; Brown, Jason; K. Buyyounouski, Mark; Chan, Kevin; Chang, Paul; I. Chin, Arnold; A. Guru, Khurshid; W. Herr, Harry; Hoffman‐Censits, Jean; Kaimakliotis, Hristos; Kundu, Shilajit; M. Lele, Subodh; Luckenbaugh, Amy; Maldonado, Jonathan; Mei, Lin; S. Montgomery, Jeffrey; Parikh, Mamta; Patterson, Anthony; Peyton, Charles; R. Plimack, Elizabeth; A. Preston, Mark; Richards, Kyle; Seyedin, Steven; O. Siefker‐Radtke, Arlene; Stewart, Tyler; Sundi, Debasish; Swami, Umang; Tollefson, Matthew; L. Wright, Jonathan; J. Cassara, Carly; Sliker, Bailee

doi:10.6004/jnccn.2020.0011

Public

Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology

Published in Journal of the National Comprehensive Cancer Network • Mar 1, 2020

Authors:

Thomas W. Flaig

Philippe E. Spiess

Michael Abern

Abstract

This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Bladder Cancer focuses on the clinical presentation and workup of suspected bladder cancer, treatment of non-muscle-invasive urothelial bladder cancer, and treatment of metastatic urothelial bladder cancer be...

Subject

Medicine

Bladder cancer

Cancer

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!